The exocyst complex regulates the last steps of exocytosis, which is essential to organisms across kingdoms. In humans, its dysfunction is correlated with several significant diseases, such as diabetes and cancer progression. Investigation of the dynamic regulation of the evolutionarily conserved exocyst-related processes using mutants in genetically tractable organisms such as Arabidopsis thaliana is limited by the lethality or the severity of phenotypes. We discovered that the small molecule Endosidin2 (ES2) binds to the EXO70 (exocyst component of 70 kDa) subunit of the exocyst complex, resulting in inhibition of exocytosis and endosomal recycling in both plant and human cells and enhancement of plant vacuolar trafficking. An EXO70 protein with a C-terminal truncation results in dominant ES2 resistance, uncovering possible distinct regulatory roles for the N terminus of the protein. This study not only provides a valuable tool in studying exocytosis regulation but also offers a potentially new target for drugs aimed at addressing human disease.
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endosidin2 | exocytosis | exocyst | EXO70 T he EXO70 (exocyst component of 70 kDa) protein is a component of the evolutionarily conserved octameric exocyst complex that tethers post-Golgi vesicles to the plasma membrane before SNARE-mediated membrane fusion (1) . As an important component of the exocyst complex that mediates exocytosis, EXO70 regulates, for example, neurite outgrowth, epithelial cell polarity establishment, cell motility, and cell morphogenesis in animal cells (2) (3) (4) (5) (6) . In plants, EXO70 proteins participate in polarized pollen tube growth, root hair growth, deposition of cell wall material, cell plate initiation and maturation, defense, and autophagy (7) (8) (9) (10) (11) (12) . In humans, EXO70 mediates the trafficking of the glucose transporter Glut4 to the plasma membrane that is stimulated by insulin and involved in the development of diabetes (13) . A specific isoform of human EXO70 is also involved in cancer cell invasion (13) (14) (15) . Endosidin2 (ES2) was identified from a plantbased chemical screen as an inhibitor of trafficking. We demonstrate that the target of ES2 is the EXO70 subunit of the exocyst and that ES2 is active in plants and mammalian systems. Significantly, no inhibitor of the exocyst complex has been reported, yet such compounds could be important for understanding the basic mechanisms of exocyst-mediated processes, for modifying secretion in biotechnological applications, and for the development of potential new drugs with higher affinity and more potent activity to control exocyst-related diseases.
Results

ES2 Inhibits
Trafficking to the Plasma Membrane. ES2 is a previously identified plant endomembrane trafficking disruptor (Fig. 1A ) that inhibits polarized growth of pollen tubes in a dose-dependent manner ( Fig. S1 A and B) (16) . Arabidopsis seedlings grown on media containing ES2 have shorter roots and fewer and shorter root hairs and are less sensitive to gravity stimulation (Fig. S1 C-G) . ES2 disrupted the trafficking of proteins that are actively recycled between the plasma membrane and endosomes, such as the brassinosteroid receptor (BRI1) and the auxin transporters PINFORMED1 (PIN1) and PIN2 after short time treatment (2 h) ( Fig. S2A) (16, 17) . Although ES2 was originally identified from the same phenotype cluster as bioactive compounds ES1 and ES3, it did not target the same proteins as ES1 and ES3 because it did not induce aggregation of trans-Golgi network marker SYP61 compared with ES1 and did not affect ROP6 localization compared with ES3, respectively ( Fig. S2A) (16, 17) . ES2 also did not affect the localization of cellular markers such as HDEL:GFP [endoplasmic reticulum (ER)], GOT1p:YFP (Golgi), SYP22:YFP [tonoplast and prevacuolar compartment (PVC)], PGP4:GFP (plasma membrane), or PIP2a:GFP (plasma membrane) (Fig. S2B) .
We further explored ES2 effects at the cellular level using GFPtagged PIN2 protein because it is known to traffic to the plasma membrane, endosomes, and vacuoles (18) (19) (20) (21) . Short term ES2 treatment reduced the amount of the plasma membrane-localized PIN2 compared with control seedlings, as shown by a fluorescence intensity plot profile in time-lapse images of PIN2:GFP seedlings
Significance
The exocyst complex is a conserved protein complex that tethers the secretory vesicles to the site of membrane fusion during exocytosis, an essential cellular process that transports molecules, such as protein, to the cell surface or extracellular space. We identified a small molecule that targets the EXO70 (exocyst component of 70 kDa) subunit of the exocyst complex to inhibit exocytosis. This compound made it possible to control the dynamics of the exocytosis process in a dosage-dependent manner in different organisms and overcame the mutant lethality and genetic redundancy issues in studying mechanisms of exocyst complex regulation. Further design of molecules with higher affinity and more potent activity may make it possible to use drugs to control human diseases related to exocytosis, such as cancer and diabetes.
treated with DMSO or ES2 (Fig. 1 B-E) . The mean fluorescence intensity of total plasma membrane-localized PIN2:GFP in seedlings treated with ES2 (90.6 ± 13.7, mean ± SD, n = 30) was significantly lower than that in seedlings treated with DMSO (118.3 ± 17.9, mean ± SD, n = 30) (P < 0.05). When we performed ES2 treatment of PIN2::PIN2:GFP-expressing seedlings in the dark to inhibit vacuolar-localized GFP fusion protein degradation (22) , we found an increased amount of GFP fluorescence in the vacuoles compared with the control (Fig. 1F) . The results indicated that ES2 treatment inhibited trafficking to the plasma membrane, and, as a consequence, the trafficking to the vacuole for degradation is enhanced.
The feret diameter of PIN2-localized compartments observed from fluorescence confocal microscope images upon ES2 treatment under light conditions was 1.18 ± 0.47 μm (mean ± SD, n = 391, from 107 cells of 11 seedlings), with a maximum feret diameter of 2.9 μm and a minimal feret diameter of 0.4 μm (Fig. 1G) . Size distribution of ES2-induced PIN2 agglomerations indicates that they are very different from known brefeldin A (BFA)-induced agglomerations resulting from abnormal trafficking at the Golgi. PIN2 vacuolar trafficking involves the retromer complex, including its component Sorting Nexin1 that colocalizes with ARA7/RabF2b endosomes (19, 20) . We found that, in seedlings expressing both PIN2::PIN2:GFP and ARA7/RabF2b:mRFP, the ES2 treatment induced PIN2 accumulation in the ARA7/RabF2b endosomal compartments (Fig. 1H) . We manually examined 338 PIN2 agglomerations from roots of 12 seedlings treated with ES2 and found that all of these agglomerations had partial or complete colocalization with ARA7/RabF2b-labeled late endosomes/PVC. Accumulation of PIN2 in ARA7/RabF2b-positive compartments was consistent with our observation that ES2 reduced PIN2 plasma membrane localization and that PIN2 trafficking to the vacuole is increased.
We next examined whether a reduced quantity of PIN2 at the plasma membrane was a result of reduced PIN2 recycling. The PIN2::PIN2:GFP seedlings grown on normal media were treated with BFA for 2 h and then permitted to recover in liquid media containing either ES2 or DMSO for another 1.5 h before imaging. We found that the disappearance of BFA bodies in ES2-treated seedlings showed a significant delay in comparison with the DMSO containing media ( Fig. 1 I and J) , indicating that ES2 treatment reduced PIN2 recycling through endosomes. Similar delayed PIN2 recycling has been observed in mutants that are defective in exocytosis (23) .
The ES2 molecule contains an N-acyl hydrazone group at its core and could have the propensity for hydrolysis to 3-fluorobenzohydrazide and 4-hydroxy-3-iodo-5-methoxybenzaldehyde in aqueous solution (Fig. S3A) . To confirm whether ES2 is stable in our system, we tested the stability of ES2 in a water solution using 1 H NMR analysis. We collected 1 H NMR spectra of ES2 at different time points over a course of 1 wk and observed no hydrolysis products under these conditions (Fig. S3B) . In addition, we tested the activity of the two possible ES2 hydrolysis products in inducing PIN2 localization in late endosomal compartments. We found PIN2 localization at the plasma membrane after we treated PIN2::PIN2:GFP seedlings with 40 μM 3-fluorobenzohydrazide or 4-hydroxy-3-iodo-5-methoxybenzaldehyde for 2 h, similar to what we observed in the DMSO control, but significantly different from the intracellular localization pattern in ES2 treated samples ( Fig.  S3 C-F). These data showed that ES2 is a stable compound under aqueous solution and that the induced trafficking phenotypes are not due to any in situ hydrolysis byproducts.
Overall, we concluded that ES2 reduced trafficking to the plasma membrane and that protein trafficking to the vacuole is increased as a consequence. This observation suggests a possible mechanism to regulate the dynamics of vesicle trafficking.
EXO70A1 Is a Cellular Target of ES2. Structure-activity relationship (SAR) analysis was performed to identify moieties in ES2 that were dispensable for its activity based on the induction of PIN2 localization in agglomerations ( Fig. 2A and Fig. S4 ). We found that the iodine in the molecule was necessary for its activity whereas the benzoic ring with the fluorine could accommodate different atoms while maintaining activity. To generate analogs with biotin to facilitate target identification, we synthesized new active and inactive analogs with an amine group in the benzoic ring with the fluorine named analog-688 (Ana-688) and analog-680 (Ana-680), as active and inactive analogs, respectively ( Fig. 2 B and D) . These two analogs were further modified to produce biotinylated molecules using the amine group and named Bio-688 and Bio-680, respectively ( Fig.  2 C and E) (see SI Materials and Methods for schemes and Dataset S1 for characterization of synthesized compounds). Ana-688 and Bio-688 induced PIN2 agglomerations after short-term treatment whereas Ana-680 and Bio-680 did not, indicating they could be used as active analogs and inactive analogs, respectively.
Bio-688 and Bio-680 were coupled to streptavidin agarose, resulting in active and inactive matrices, respectively, which were incubated with Arabidopsis cell extracts. Proteins bound to the active and inactive matrices were eluted by ES2, and the eluted fractions were analyzed using mass spectrometry (MS). Although the peptide abundance in the elution fractions was low (Dataset S2), we detected a peptide from Arabidopsis EXO70G2, which belongs to the EXO70 family in Arabidopsis that is involved in exocytosis, from the active matrix but not the inactive matrix elution. EXO70G2 belongs to the EXO70 family that has 23 members in Arabidopsis divided into subclasses A to H (7, 24, 25). EXO70A1, which shares 24% amino acid sequence identity with that of EXO70G2, is a member of the EXO70 family that has been well-studied, and there are resources available for us to do further investigation. We then took other approaches to test for possible interaction between ES2 and EXO70 proteins in Arabidopsis. Using an available EXO70 antibody, we further tested the presence of a close paralog EXO70A1 on the matrix by Western blot (Fig. 2F) (7-9, 23, 26) . The intensity of the Western blot bands indicated that the Bio-688 matrix was more potent in pulling down EXO70A1, in comparison with the Bio-680 matrix and biotin controls, indicating that EXO70A1 interacted more strongly with the active ES2 analog compared with the inactive analog.
We took a relatively new approach for chemical target identification called drug affinity responsive target stability (DARTS) to test the interaction between ES2 and EXO70A1 (27) . The DARTS approach was developed based on the observation that some proteins are protected from degradation by proteases when bound to the ligand (27) . We incubated an Arabidopsis protein extract with ES2 or DMSO and then digested with different concentrations of proteases. After normalizing EXO70A1 protein Western blot band intensity against that of the actin internal control, we found that the degradation of EXO70A1 was significantly protected by ES2 compared with actin, which was detected on the same blotting membrane at protease dilutions of 1:3,000 and 1:10,000 (Fig. 2G) . We further expressed and purified the EXO70A1 protein from Escherichia coli and tested for its interaction with ES2, using saturation-transfer difference NMR (STD-NMR) (28) . EXO70A1 amino acid residues 75-638 were used for STD-NMR due to the instability of the full-length protein (Fig. 2H) . The 1 H assignments of ES2 in DMSO-d 6 were determined from gCOSY (gradient correlation spectroscopy) and gNOESY (gradient nuclear overhauser effect spectroscopy) spectral analysis ( Fig. S5 A and B and Table 1 ). Assignments in D 2 O were made by comparison with the 1D spectrum recorded in DMSO-d 6 . To determine the optimum saturation time, an STD build-up curve was generated using 400 μM ES2 and 20 μM EXO70A1 samples (Fig. S6C) . The build-up curve (Fig. 2I) clearly indicated that there was direct interaction between ES2 and EXO70A1. The 1 H spectral peak from an unrelated molecule showed no interaction with EXO70A1 (Fig. 2I, arrow) . Based on the results from the build-up curve, all further STD-NMR measurements were taken using a 2-s saturation time. We titrated EXO70A1 with different concentrations of ES2 in an STD-NMR experiment, and the STD amplification factor was calculated as a function of ES2 concentration (Fig. 2J) . The dissociation constant (K d ) of the EXO70A1 and ES2 interaction using STD-NMR was 400 ± 170 μM and the B max was 12.9 ± 2.74 (Table 2) . We also performed the 1 H assignments of ES2 analog8 (Table S1 and Fig.  S5D ), an inactive analog, and studied the interaction between analog8 and EXO70A1 using STD-NMR. The calculated STD amplification factors did not show a significant increase, with elevated concentrations of analog8 (Fig. 2J ). This result confirmed that the detected interaction between ES2 and EXO70A1 using STD-NMR is not due to random interaction of any small molecule with EXO70A1 protein. To further confirm results from STD-NMR, we used the technique of microscale thermophoresis (MST) to quantify the dissociation constant for the complex of ES2 (titrant) with EXO70A1 (target molecule). This method observes the motion of molecules in response to a temperature gradient (29) (30) (31) . Thermophoresis is characterized by monitoring the timedependent fluorescence, referred to as a time trace, of a labeled target molecule in a small zone subject to localized heating by an infrared laser (30) (Table 2) . Moreover, when MST is performed for the interaction of a negative control, analog8, with EXO70A1, we observed no change in thermophoretic behavior as expected (Fig. 2K ).
We concluded from these different assays that ES2 interacted with EXO70A1 in vitro, suggesting that it could be a target in vivo.
The Expression of EXO70A1 N Terminus Results in Desensitization to
ES2. To investigate the relationship between ES2 and the EXO70 gene family at the genetic level, we tested root growth phenotypes of available exo70 mutants as listed in Table S2 , in the presence of ES2. None of the 24 mutants that we tested displayed significant differences in response to ES2 compared with WT, except one. Heterozygous seedlings of T-DNA (transfer DNA) insertion allele exo70A1-3 (SALK_026036C) showed resistance to ES2 in root growth (Fig. 3A) . To study the response of T-DNA insertion mutant plants to ES2 at the cellular level, we crossed PIN2::PIN2: GFP with exo70A1-3 heterozygous plants. The F3 population from an F2 seedling that was homozygous for PIN2::PIN2:GFP and heterozygous for T-DNA insertion was used to study the difference between WT plants and exo70A1-3 heterozygous plants. Upon ES2 treatment, heterozygous T-DNA insertion mutant seedlings showed smaller and fewer PIN2 agglomerations compared with WT seedlings from the same segregating population (Fig. 3 B-E) . Although heterozygous exo70A1-3 seedlings had normal growth at the seedling stage, the plants had retarded growth after bolting, more shoot stems, reduced seed yield, and abnormal flower development (Fig. S6A) . Homozygous exo70A1-3 seedlings had severe growth phenotypes that included arrested root growth and abnormal root meristem organization and were seedling lethal (Fig. S6B) , similar to previously characterized exo70A1-1 and exo70A1-2 mutant alleles, but were more severe (7). The more severe phenotypes in exo70A1-3 homozygous plants were reported previously, and it was not understood why this T-DNA insertion line caused the severe phenotypes (32) . We decided to further characterize this allele to find out the linkage between T-DNA insertion in EXO70A1 and ES2 resistance. We analyzed the homozygous mutant at the transcription level and found that it accumulated the 5′ end of the EXO70A1 mRNA upstream of the T-DNA insertion site whereas the 3′ end of mRNA downstream of the T-DNA insertion was not detected (Fig. 3 F and G) . We suspected that this mutation resulted in dominant resistance due to the truncated mRNA encoding a stably accumulated N-terminal peptide that caused the severe phenotypic defect in exo70A1-3. In contrast, exo70A1-1 and -2 were reported as null and knockdown alleles that exhibit a milder phenotype (7) . This observation led us to characterize the mutant allele at the protein level.
The expected mass of the truncated peptide was ∼25 kDa, with 231 amino acids. Because the anti-EXO70A1 antibodies did not recognize the N-terminal region of EXO70A1, we took advantage of mass spectrometry analysis. We first surveyed the E. coli- expressed EXO70A1 protein with nano-LC/MS/MS (liquid chromatography/mass spectrometry/mass spectrometry) and identified a peptide ion from its N-terminal region (amino acids 90-109) with strong signal intensity (Fig. S7) . Using this peptide ion with known m/z, charge state, and retention time as the fingerprint for EXO70A1, we then analyzed plant proteins derived from WT and the T-DNA line. We analyzed SDS gel bands with approximate masses of 70 kDa and 25 kDa, respectively, from both the WT and exo70A1-3 mutant using nano-LC/MS (the system was confirmed with no background after blank injection). It was found that the amino acid 90-109 fingerprint was detected in WT 70-kDa and exo70A1-3 25-kDa samples (Fig. 3H) , indicating that the exo70A1-3 allele accumulates a truncated peptide in planta that might be responsible for the ES2 resistance. To test the contribution of the truncated peptide to the growth resistance of the exo70A1-3 mutant, we expressed EXO70A1 amino acids 1-231 in WT plants under the Cauliflower Mosaic Virus 35S promoter and then analyzed the effect of ES2 on the transgenic lines. Homozygous transgenic lines expressing the N terminus of EXO70A1 showed partial resistance to ES2 in root growth when grown on media containing lower concentrations of ES2 (Fig.  3I) . We also found resistance to ES2 when exo70A1-3 heterozygous seedlings or EXO70A1 N terminus expression seedlings were transferred from normal media to ES2-containing media (Fig. 3J) . Reproduction of ES2 resistance in transgenic lines confirmed the linkage between EXO70A1 N terminus expression and ES2 resistance. Similar to exo70A1-3 heterozygous plants, plants expressing the N-terminal truncated peptide displayed normal growth at the seedling stage in the absence of ES2, but retarded growth, small stature, reduced seed yield, and flower development defects after bolting on soil (Fig. S8) . Thus, we concluded that the EXO70A1 N-terminal peptide was sufficient to induce dominant ES2 resistance in plants, and this observation confirmed in planta that EXO70A1 was a target of ES2. This observation also suggested that the exocyst could be an important site for controlling the dynamics between recycling to the plasma membrane and vacuole targeting and that the N-terminal domain probably served distinct roles in exocyst regulation. Heterozygous exo70A1-3 plants show developmental phenotypes in later stages of plant development, which is similar to the EXO70A1 N-terminal peptide expression line. This observation may also reflect the regulatory roles of the EXO70A1 N-terminal domain and the contribution of EXO70A1 to different stages of plant development. Although further investigation is needed to understand the underlying cellular mechanisms for the roles of the EXO70A1 N terminus region in regulating exocytosis and in plant development, the genetic resistance in the mutant and transgenic lines confirms the linkage between ES2 and exocyst regulation at the genetic level.
ES2 Inhibits Cellular Dynamics of EXO70A1. To discover whether ES2 inhibited EXO70 cellular dynamics directly, we examined the cellular localization of GFP-tagged EXO70A1 (GFP:EXO70A1) in Arabidopsis root cells upon ES2 treatment. GFP:EXO70A1 showed plasma membrane localization with distinct polarized maximum at the outer lateral side of root epidermal cells in the root tip (Fig. 4A, white arrows) . We found that, upon ES2 treatment, the polarized localization pattern of EXO70A1 was lost (Fig. 4 A-C) . Plot of fluorescence intensity across the root transition zone in DMSO-treated control seedlings revealed high fluorescence intensity in the outside layer of the root epidermal cells (Fig. 4B) . After 2 h of 40 μM ES2 treatment, the lateral polarity of EXO70A1 was changed, as reflected by reduced fluorescence intensity at the outside layer of root epidermal cells (Fig. 4C) . The mean fluorescence intensity of lateral GFP: EXO70A1 in ES2-treated seedlings (32.0 ± 12.2, mean ± SD, n = 10) was significantly lower than DMSO control seedlings (88.1 ± 18.6, mean ± SD, n = 10) (P < 0.05). However, the lateral polarity pattern of two other exocyst components, EXO84 and SEC8, was not affected (Fig. S9A, white arrows) . In root hair cells, where active exocytosis is required for polarized growth (33, 34) , it was found that, upon ES2 treatment, the fluorescence recovery of GFP:EXO70A1 after photobleaching was significantly slower compared with control cells (Fig. 4D) . The maximum fluorescence recovery was more than 80% of the prebleached intensity within 3 min in control cells whereas the fluorescence recovery was limited to 20% of the prebleached level at the same time in cells treated with ES2 (Fig. 4E ). This result indicated that ES2 significantly inhibited the cellular dynamics of EXO70A1 in root hair cells as well. The fact that ES2 strongly interfered with EXO70A1 localization without perturbing two other exocyst subunits further supported that, in planta, EXO70A1 was a target of ES2. The specificity of mislocalization suggests that the mechanism of EXO70A1 lateral plasma membrane targeting is distinct from that of other exocyst components. Furthermore, EXO70A1 may dissociate from the complex independently from other subunits, indicating that the maintenance of its lateral polarity may be distinct (assuming that EXO84, SEC8, and EXO70A1 are part of the exocyst while at the lateral plasma membrane). Furthermore only lateral polarity was affected (not isolateral localization), indicating that EXO70A1 lateral polarity is distinct.
ES2 Targets EXO70 to Inhibit Recycling in Mammalian Cells. Due to the evolutionary conservation of the composition and function of the exocyst complex, we were interested in investigating whether ES2 can target EXO70 in other systems. We examined whether ES2 would affect exocytosis in human cells using the transferrin (Tfn) recycling assay, which measures the recycling of endocytosed transferrin to the plasma membrane. The assay has been commonly used to study protein trafficking to the plasma membrane. After treatment with DMSO as a control or ES2 for 1 h, the cells were pulsed with Tfn-AlexaFluor488 on ice for 5 min and chased with complete media to track Tfn trafficking over time. Most of the Tfn was exocytosed after a 90-min chase in cells treated with DMSO (Fig. 5A) . However, Tfn accumulated markedly at the protrusion sites of cells treated with ES2, indicating that exocytosis was reduced. Comparison of the ratio of Tfn retention at 30 min and 90 min after chasing with that of 5 min after chasing in DMSO-and ES2-treated cells indicated reduced Tfn trafficking in ES2-treated cells (Fig. 5B) . To test whether the reduced exocytosis in mammalian cells was related to EXO70 as in plants, we tested the localization of GFP-tagged rat EXO70 (rEXO70) protein after ES2 treatment. We found that ES2 treatment induced the accumulation of EXO70 vesicles near the plasma membrane (Fig. 5C) . A similar effect was observed for human EXO70 isoform2 and isoform5 proteins upon ES2 treatment (Fig. S9B ). These vesicles may suggest a block of vesicle tethering and fusion with plasma membrane. To test direct interaction between ES2 and rEXO70, we purified E. coliexpressed rEXO70 (Fig. 5D ) and performed an STD-NMR experiment. The interaction between ES2 and rEXO70 was confirmed by the presence of saturation energy transfer (Fig. 5E ). These data confirm that ES2 directly targets EXO70 in vivo to inhibit exocytosis in mammalian cells as well as in plants. It further indicates that, in human cells, ES2 can target multiple isoforms of EXO70, resulting in misregulation of exocytosis.
The fact that plant and mammalian EXO70 proteins are targets of ES2 suggests structural similarity. To better understand the structural basis for the conservation of the altered regulation of EXO70A1 by ES2, we crystallized Arabidopsis EXO70A1 and determined its structure at 3.1-Å resolution. The crystal structure of EXO70A1 revealed that it adopted an elongated architecture resembling that previously observed for yeast (35, 36) and mouse EXO70 (mEXO70) (37) . We were able to trace 17 α-helices in the structure, which were further divided into three domains based on interdomain hinge points and the overall arrangement of helices: N-terminal (75-379), C-terminal (511-629), and middle (380-510) connecting the N-and C-terminal domains (Fig.  6A) (36) . The relative conformations of the three domains in EXO70A1 and mEXO70 were similar, except for a slight difference in the orientation of the N-terminal domain. Superposition of the middle C-terminal domains of EXO70A1 and mEXO70 gave a root mean square deviation (rmsd) of 1.59 Å on 147 Cα atoms (Fig. 6B ). We were able to trace all of the helices in the final structure, except that a number of loops connecting the helices were missing due to poor electron density. The statistics for the X-ray diffraction data and structure are summarized in Table 3 . Such a high structural similarity suggested that, despite low sequence identity (32% in middle C-terminal domains), the biochemical functions of plant and mammalian EXO70 proteins were most likely conserved. This result supported our conclusion that ES2 targets EXO70 in plants and three mammals (rats, humans, and, probably, mice).
With an available crystal structure of EXO70A1, a molecular docking tool, Autodock, was applied to predict possible ES2 binding sites of the EXO70A1, by fixing the protein and allowing ES2 to freely bind to several potential pockets of the EXO70A1. We decided to use molecular docking to predict possible ES2 binding sites on EXO70A1. Using Autodock (38), we found one possible binding pocket located at the C terminus of EXO70A1. The binding cavity was principally composed of the hydrophobic amino acids Y592, L596, K597, P601, R598, I613, and T616 (Fig.  6C) . The conformation of ES2 can fit well in the C-terminal pocket of the WT EXO70A1 protein. The fluorine-containing aromatic ring of ES2 locates in the cavity created by P601, R598, and K597 main chains. The iodine-containing aromatic ring is surrounded by hydrophobic sidechains of several residues, including I613, L596, Y592, and T616. When we performed the docking with mutations of L596 and I613 to Ala, the binding pocket became larger because of the missing of I613 and L596 sidechains. However, in this case, the ES2 conformation couldn't fit the pocket properly (Fig. 6D) . Although the iodine-containing aromatic ring remained deeply in the pocket and formed interactions with A613, fewer interactions between the fluoride-containing aromatic ring and Y592/A596 were shown. In addition, in contrast to WT EXO70A1, the L596A and I613A mutations resulted in missing attractions between the ES2 and P601, R598, and T616, which would generate higher binding free energy and a weaker ligand-binding mode. To confirm that the predicted pocket plays a role in ES2 binding, we mutated amino acids L596 and I613 to Alanine (L596A;I613A) and tested for the binding activity of mutant protein to ES2 using STD-NMR. We found that, under the same protein and ES2 concentrations, L596A;I613A had less binding to ES2, which was reflected by reduced STD-NMR integral integrity ( Fig. 6 E and F and Fig. S10 A and B) . This observation was consistent with the prediction that L596 and I613 participate in interaction with ES2 although the mutations did not completely abolish the interaction between EXO70A1 and ES2. We also compared the thermophoretic mobility of EXO70A1 and EXO70A1-L596A;I613A when titrated with ES2 (Fig. 6G) . Although the maximal thermophoretic mobility was lower for the mutated protein than for EXO70A1, the K d of 252 ± 50.6 for the interaction of ES2 with EXO70A1-L596A;I613A is not significantly different at a 95% level of confidence than the K d for ES2 with EXO70A1 (Table 2) . Despite this result, the nonlinear fit for the interaction of ES2 with EXO70A1 is more robust with an R-squared of 81.7% than for the interaction of ES2 with EXO70A1-L596A;I613A, with an R-squared of 46.5%. This observation suggested that amino acids L596 and I613 were not essential for binding of ES2 but may interact with binding site residues and indirectly affect the local binding microenvironment. Amino acids L596 and I613 are conserved between Arabidopsis EXO70A1 and mammalian EXO70 proteins (Fig.  S10C) , explaining why ES2 could interact with both Arabidopsis EXO70A1 and rat EXO70.
Discussion
In summary, the previously unidentified small molecule ES2 directly interacts with and inhibits the dynamics of the evolutionarily conserved EXO70 proteins to reduce exocytosis in plants and mammals and enhance plant vacuolar trafficking. Expression of the EXO70A1 N terminus in WT plants partially overcomes the effects of ES2, indicating that this region might positively regulate plasma membrane docking of the full-length protein.
Despite the high divergence in their primary protein structure, plant and mammalian EXO70 proteins share an evolutionarily conserved structure that likely permits ES2 to target EXO70 proteins in plants and humans. This result is the first report, to our knowledge, of the structure of a plant EXO70 subunit. The similarities in 3D structure strongly support a conservation of exocyst function and functional sites during evolution. Despite these new details, it is unclear how the exocyst is integrated within the context of the endomembrane trafficking system in multicellular organisms. In Arabidopsis, there are 23 genes encoding EXO70 isoforms, more than in mammals or yeast. Most of these isoforms are poorly defined in terms of function. Our result in human cells is powerful in that it indicates that ES2 will probably target many EXO70 isoforms and shows the power of chemical genomics in addressing genetic redundancy. It also indicates that, by using a high content, cell biology-based pollen screen for modulators of endomembrane trafficking, we have found a molecule that will permit us to investigate the basic functional domains of EXO70. Although beyond the scope of this study, the functional roles of the N-terminal and C-terminal domains now can be investigated in more detail to understand the regulation of exocyst-related vesicle transport processes, especially the dynamics and regulation of trafficking toward the vacuole or plasma membrane, which are altered by ES2. The structure of EXO70A1 will also be of value in further modeling the ES2 binding site. This approach may also provide a new avenue toward novel drugs. To date, we are not aware of any small molecules that target the exocyst; thus, this discovery presents a novel drug target. It also allows further development of similar drugs with higher affinity to EXO70, with stronger drug activity in controlling exocytosis. The exact role of the exocyst in human diseases requires further investigation. It may be possible to increase the potency and modify the isoform specificity of ES2 or similar molecules targeting EXO70 to control EXO70-related human diseases, such as cancer cell invasions and diabetes, which involves glucose transport. Although the sequence identity between plant EXO70s and yeast EXO70 is lower than that of mammalian cells, we found that I613 is conserved between plant and yeast EXO70s. It is possible that ES2 can target yeast EXO70 as well and thus can be a potential tool in fungal pathogen manipulation.
Materials and Methods
DARTS and STD-NMR assays were developed from published protocols (39, 40) . The EXO70A1 protein was expressed in E. coli and purified for STD-NMR, MST, and crystallization experiments. The sources of Arabidopsis transgenic lines and the detailed methods are listed in SI Materials and Methods.
Dataset S1 contains information on 1 H, 13 C, and 19 F NMR spectra of the synthesized compounds, and Dataset S2 contains information on the peptides detected from the pull-down assay using biotin-tagged analogs combined with mass spectrometry analysis.
